| New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury FS Santiago, HC Lowe, MM Kavurma, CN Chesterman, A Baker, ... Nature medicine 5 (11), 1264-1269, 1999 | 375 | 1999 |
| Vascular smooth muscle cell senescence in atherosclerosis I Gorenne, M Kavurma, S Scott, M Bennett Cardiovascular research 72 (1), 9-17, 2006 | 259 | 2006 |
| Signaling and transcriptional control of Fas ligand gene expression MM Kavurma, LM Khachigian Cell Death & Differentiation 10 (1), 36-44, 2003 | 197 | 2003 |
| Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis HC Lowe, RG Fahmy, MM Kavurma, A Baker, CN Chesterman, ... Circulation research 89 (8), 670-677, 2001 | 148 | 2001 |
| ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes MM Kavurma, LM Khachigian Journal of cellular biochemistry 89 (2), 289-300, 2003 | 142 | 2003 |
| TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice BA Di Bartolo, J Chan, MR Bennett, S Cartland, S Bao, BE Tuch, ... Diabetologia 54, 3157-3167, 2011 | 131 | 2011 |
| The walking dead: macrophage inflammation and death in atherosclerosis MM Kavurma, KJ Rayner, D Karunakaran Current opinion in lipidology 28 (2), 91-98, 2017 | 123 | 2017 |
| TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-κB and induction of insulin-like growth factor-1 receptor MM Kavurma, M Schoppet, YV Bobryshev, LM Khachigian, MR Bennett Journal of Biological Chemistry 283 (12), 7754-7762, 2008 | 122 | 2008 |
| Vessel wall apoptosis and atherosclerotic plaque instability MM Kavurma, R Bhindi, HC Lowe, C Chesterman, LM Khachigian Journal of Thrombosis and Haemostasis 3 (3), 465-472, 2005 | 115 | 2005 |
| Sp1 phosphorylation regulates apoptosis via extracellular FasL-Fas engagement MM Kavurma, FS Santiago, E Bonfoco, LM Khachigian Journal of Biological Chemistry 276 (7), 4964-4971, 2001 | 110 | 2001 |
| TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2–, Sp1 Phosphorylation–, and NFκB-Dependent Manner J Chan, L Prado-Lourenco, LM Khachigian, MR Bennett, BA Di Bartolo, ... Circulation research 106 (6), 1061-1071, 2010 | 103 | 2010 |
| Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation MM Kavurma, LM Khachigian Journal of Biological Chemistry 278 (35), 32537-32543, 2003 | 99 | 2003 |
| Death receptors and their ligands in atherosclerosis MM Kavurma, NY Tan, MR Bennett Arteriosclerosis, thrombosis, and vascular biology 28 (10), 1694-1702, 2008 | 88 | 2008 |
| Expression, regulation and function of trail in atherosclerosis MM Kavurma, MR Bennett Biochemical pharmacology 75 (7), 1441-1450, 2008 | 87 | 2008 |
| Ets-1 positively regulates Fas ligand transcription via cooperative interactions with Sp1 MM Kavurma, Y Bobryshev, LM Khachigian Journal of Biological Chemistry 277 (39), 36244-36252, 2002 | 86 | 2002 |
| TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL BA Di Bartolo, SP Cartland, HH Harith, YV Bobryshev, M Schoppet, ... PloS one 8 (9), e74211, 2013 | 80 | 2013 |
| Colchicine inhibits neutrophil extracellular trap formation in patients with acute coronary syndrome after percutaneous coronary intervention K Vaidya, B Tucker, R Kurup, C Khandkar, E Pandzic, J Barraclough, ... Journal of the American Heart Association 10 (1), e018993, 2021 | 76 | 2021 |
| Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification BA Di Bartolo, M Schoppet, MZ Mattar, TD Rachner, CM Shanahan, ... Cardiovascular research 91 (3), 537-545, 2011 | 76 | 2011 |
| On the TRAIL of obesity and diabetes HH Harith, MJ Morris, MM Kavurma Trends in Endocrinology & Metabolism 24 (11), 578-587, 2013 | 71 | 2013 |
| Tumor Necrosis Factor–Related Apoptosis‐Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia‐Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide … BA Di Bartolo, SP Cartland, L Prado‐Lourenco, TS Griffith, C Gentile, ... Journal of the American Heart Association 4 (11), e002527, 2015 | 64 | 2015 |
Sian CartlandThe Heart Research Institute, Sydney, Australia在 hri.org.au 的电子邮件经过验证
